Compounds > 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid
Page last updated: 2024-10-21

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Primary Peritonitis

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with Primary Peritonitis in 1 studies

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid: structure given in first source; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hung, ND1
Kim, MR1
Sok, DE1

Other Studies

1 other study available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Primary Peritonitis

ArticleYear
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
    British journal of pharmacology, 2011, Volume: 162, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosapentaenoic Acid; In Vitro Techniq

2011